Kevin Tang - Nov 17, 2021 Form 4 Insider Report for Odonate Therapeutics, Inc. (ODT)

Signature
/s/ Kevin Tang
Stock symbol
ODT
Transactions as of
Nov 17, 2021
Transactions value $
-$5,730,557
Form type
4
Date filed
11/19/2021, 03:38 PM
Previous filing
Jun 1, 2021
Next filing
Nov 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ODT Common Stock Sale -$1.25M -469K -3.02% $2.66* 15M Nov 17, 2021 By LP F1, F2
transaction ODT Common Stock Sale -$62.1K -31.2K -0.21% $1.99* 15M Nov 17, 2021 By LP F2, F3
transaction ODT Common Stock Sale -$1.01M -500K -3.33% $2.02* 14.5M Nov 17, 2021 By LP F2, F4
transaction ODT Common Stock Sale -$632K -288K -1.98% $2.20* 14.2M Nov 17, 2021 By LP F2, F5
transaction ODT Common Stock Sale -$419K -212K -1.49% $1.97* 14M Nov 18, 2021 By LP F2, F6
transaction ODT Common Stock Sale -$941K -500K -3.57% $1.88* 13.5M Nov 18, 2021 By LP F2, F7
transaction ODT Common Stock Sale -$723K -382K -2.83% $1.89* 13.1M Nov 18, 2021 By LP F2, F8
transaction ODT Common Stock Sale -$700K -365K -2.78% $1.92* 12.8M Nov 19, 2021 By LP F2, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $2.01 to $3.01. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 1 and 3 through 9 herein.
F2 The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. The shares reported as beneficially owned by TCP include a total of 154,285 shares of common stock that are held of record by Odonate Holdings, LLC ("Holdings"). Holdings has granted a proxy to TCP giving TCP the sole authority to vote such shares. Michael Hearne is the Chief Financial Officer of Odonate Therapeutics, Inc., as well as Chief Financial Officer of TCM. Mr. Tang and Mr. Hearne each have a pecuniary interest in a portion of the shares beneficially held by TCP.
F3 The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.99 to $2.005.
F4 The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.95 to $2.07.
F5 The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.33.
F6 The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.91 to $2.16.
F7 The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.85 to $1.99.
F8 The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.85 to $2.001.
F9 The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.85 to $1.985.